Shi S - Search Results

1

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.

Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, Meng Q, Yu X, Shi S. Tang R, et al. Among authors: shi s. J Hematol Oncol. 2020 Aug 10;13(1):110. doi: 10.1186/s13045-020-00946-7. J Hematol Oncol. 2020. PMID: 32778143 Free PMC article. Review.

2

Combinational therapy: new hope for pancreatic cancer?

Shi S, Yao W, Xu J, Long J, Liu C, Yu X. Shi S, et al. Cancer Lett. 2012 Apr 28;317(2):127-35. doi: 10.1016/j.canlet.2011.11.029. Epub 2011 Dec 2. Cancer Lett. 2012. PMID: 22138436 Review.

3

microRNA signature for human pancreatic cancer invasion and metastasis.

Cheng H, Shi S, Cai X, Long J, Xu J, Liu C, Yu X. Cheng H, et al. Among authors: shi s. Exp Ther Med. 2012 Aug;4(2):181-187. doi: 10.3892/etm.2012.585. Epub 2012 May 21. Exp Ther Med. 2012. PMID: 22970025 Free PMC article.

4

Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties.

Luo G, Long J, Cui X, Xiao Z, Liu Z, Shi S, Liu L, Liu C, Xu J, Li M, Yu X. Luo G, et al. Among authors: shi s. Int J Oncol. 2013 Mar;42(3):979-84. doi: 10.3892/ijo.2013.1780. Epub 2013 Jan 18. Int J Oncol. 2013. PMID: 23338123

5

LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process.

Qin Y, Zhu W, Xu W, Zhang B, Shi S, Ji S, Liu J, Long J, Liu C, Liu L, Xu J, Yu X. Qin Y, et al. Among authors: shi s. Cancer Lett. 2014 Jun 1;347(2):225-32. doi: 10.1016/j.canlet.2014.02.013. Epub 2014 Feb 18. Cancer Lett. 2014. PMID: 24561118

6

Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival.

Xu YF, Lu Y, Cheng H, Shi S, Xu J, Long J, Liu L, Liu C, Yu X. Xu YF, et al. Among authors: shi s. Pancreatology. 2014 Jul-Aug;14(4):295-301. doi: 10.1016/j.pan.2014.05.797. Epub 2014 Jun 11. Pancreatology. 2014. PMID: 25062880

7

Stathmin destabilizing microtubule dynamics promotes malignant potential in cancer cells by epithelial-mesenchymal transition.

Lu Y, Liu C, Xu YF, Cheng H, Shi S, Wu CT, Yu XJ. Lu Y, et al. Among authors: shi s. Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):386-94. doi: 10.1016/s1499-3872(14)60038-2. Hepatobiliary Pancreat Dis Int. 2014. PMID: 25100123 Review.

8

Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis.

Yao W, Ji S, Qin Y, Yang J, Xu J, Zhang B, Xu W, Liu J, Shi S, Liu L, Liu C, Long J, Ni Q, Li M, Yu X. Yao W, et al. Among authors: shi s. Mol Cancer. 2014 Aug 7;13:187. doi: 10.1186/1476-4598-13-187. Mol Cancer. 2014. PMID: 25103363 Free PMC article.

9

Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer.

Shi S, Ji S, Qin Y, Xu J, Zhang B, Xu W, Liu J, Long J, Liu C, Liu L, Ni Q, Yu X. Shi S, et al. Cancer Lett. 2015 May 1;360(2):227-33. doi: 10.1016/j.canlet.2015.02.014. Epub 2015 Feb 14. Cancer Lett. 2015. PMID: 25687883

10

ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.

Ji S, Qin Y, Shi S, Liu X, Hu H, Zhou H, Gao J, Zhang B, Xu W, Liu J, Liang D, Liu L, Liu C, Long J, Zhou H, Chiao PJ, Xu J, Ni Q, Gao D, Yu X. Ji S, et al. Among authors: shi s. Cell Res. 2015 May;25(5):561-73. doi: 10.1038/cr.2015.30. Epub 2015 Mar 10. Cell Res. 2015. PMID: 25753158 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,455 results

Search Page

Filters